More articles from Guidelines to Practice
- Managing stage 1 hypertension: Consider the risks, stop the progression
Guidelines on managing patients with stage 1 hypertension and a low 10-year risk of atherosclerotic cardiovascular disease.
- Anaphylaxis: Highlights from the practice parameter update
The update addresses diagnostic criteria, treatment options, prevention of recurrences, and patient education on avoiding triggers and using self-injectable epinephrine.
- Updated guidelines for immune thrombocytopenic purpura: Expanded management options
The aim is to help practitioners decide on inpatient vs outpatient management, thresholds for initiating treatment, and options for second-line treatment in adults.
- Risk-based guidelines: Redefining management of abnormal cervical cancer screening results
A shift from results-based to risk-based management, based on the patient’s immediate and 5-year risks of grade 3 or higher cervical intraepithelial neoplasia.
- Outpatient management of asthma in adults: A snapshot of the 2020 GINA report
A review of the guidelines, with a focus on what’s new and clinically important.
- Reversal of direct oral anticoagulants: Highlights from the Anticoagulation Forum guideline
Clear instructions on how to manage DOAC-associated bleeding.